Drugs / Inactivated influenza vaccine (split virus, Vero cell-derived)
Inactivated influenza vaccine (split virus, Vero cell-derived)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01157702 | Jul → Aug 2010 | influenza | Alachua Government Services, Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated influenza vaccine (split virus, Vero cell-derived) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01157702 ↗ |
| Modality | Vaccine | “Vero Cell-Derived Trivalent Seasonal Influenza Vaccine” NCT01157702 ↗ |
| Route | Intramuscular | “administered by intramuscular injection into the musculus deltoideus in the upper arm” NCT01157702 ↗ |